-
The Next Frontier in Parkinson Disease Care: Exploring Gene and Cell Therapies
30 Apr 2025 17:30 GMT
… 6. Denali Therapeutics and Biogen announce initiation of phase 2b … in Parkinson disease. News release. Biogen. May 31, 2022. Accessed … . https://investors.biogen.com/news-releases… #47;denali-therapeutics-and-biogen-announce-initiation-phase-2b
7 …
-
Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights
30 Apr 2025 16:21 GMT
… expanding opportunity in this market. Biogen’s litifilimab, which targets BDCA2 …
-
Ionis reports first quarter 2025 financial results
30 Apr 2025 11:11 GMT
… QALSODY® are registered trademarks of Biogen. WAINUATM is a registered trademark …
-
Evolving Treatment Landscape in nAMD, DME Reduces Patient Burden, Improves Outcomes: Casey Koch, PharmD
29 Apr 2025 23:19 GMT
… biosimilars Byooviz (Samsung Bioepis and Biogen) and Cimerli (Coherus Biosciences), approved …
-
Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates
29 Apr 2025 20:26 GMT
… the net revenue recorded when Biogen ships ZURZUVAE to the … to the Sage/Biogen Collaboration and License Agreement was … to the Sage/Biogen Collaboration and License Agreement was … the collaboration costs incurred by Biogen in support of ongoing …
-
Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe
29 Apr 2025 21:09 GMT
… likes of both Pfizer and Biogen.
-
Pinnacle Awards 2025: Joanna Ruiz
29 Apr 2025 18:12 GMT
… , J&J, Pfizer, NYP, Biogen, Elevance, Moderna, Integra and Sanofi …
-
Phenylketonuria Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight | DelveInsight
29 Apr 2025 17:00 GMT
… 's Disease companies, including Biogen, AZTherapies, Cerecin, Neurotrope, Synaptogenix, INmune …
-
Adalimumab Biosimilars Demonstrate Long-Term Durability and Cost-Effectiveness in Paediatric Inflammatory Bowel Disease: A Real-World Two-Centre European Cohort Study
29 Apr 2025 15:30 GMT
… =18, 14%) and SB5 (Imraldi®, Biogen International GmbH, Baar, Switzerland) (n …
-
Study shows most Americans want to know about Alzheimer’s diagnosis ASAP to allow for treatment, medication
29 Apr 2025 13:17 GMT
… infusions of lecanemab, Eisai and Biogen’s Leqembi.
“I feel like …